Zobrazeno 1 - 10
of 236
pro vyhledávání: '"Yu. A. Gorbunova"'
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 14, Iss 5, Pp 513-520 (2024)
INTRODUCTION. The commercial success of innovations in medicine and pharmaceutics depends on the strategic planning of patent protection, with the main elements for consideration being the type of patent protection, the scope of the invention, and th
Externí odkaz:
https://doaj.org/article/9937e8eb4d7e466d90e9521e94fee994
Autor:
Yu. A. Gorbunova, I. O. Boronikhina
Publikováno v:
Дискурс, Vol 8, Iss 5, Pp 5-17 (2022)
Introduction. The slow movement in universities is a reaction to the economic-centricity and commodification of higher education and science, the standardization and quantifiability of research and educational activities, the expansion of digital tec
Externí odkaz:
https://doaj.org/article/59866f5a01b54b3cb5c3365d6d33f14a
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 5, Pp 560-565 (2022)
Aim – to determine the frequency of myocardial dysfunction using echocardiography with speckle tracking (STE) method, the relationship between a low global longitudinal strain (GLS) with the level of NT-proBNP, clinical and laboratory manifestation
Externí odkaz:
https://doaj.org/article/06ec802fd35a467e8d12a5e74a7d2a0f
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 3, Pp 347-352 (2022)
Objective – to identify obesity/overweight phenotypes in patients with systemic lupus erythematosus (SLE) based on the body mass index (BMI) and serum leptin levels assessment, and to clarify the relationship of these phenotypes with different meta
Externí odkaz:
https://doaj.org/article/4895db52dc874478a063c490832a6e03
Autor:
A. V. Martynova, T. V. Popkova, A. P. Aleksankin, G. I. Gridneva, E. V. Gerasimova, Yu. N. Gorbunova, A. M. Lila
Publikováno v:
Современная ревматология, Vol 16, Iss 1, Pp 38-45 (2022)
Objective: assessment of the dynamics of T- and B-lymphocytes subpopulations in rheumatoid arthritis (RA) during therapy with synthetic disease-modifying antirheumatic drugs (sDMARDs) and biological disease-modifying antirheumatic drugs (bDMARDs): in
Externí odkaz:
https://doaj.org/article/17ef735ea5fa4fdd81c88ecfb2655910
Publikováno v:
Современная ревматология, Vol 15, Iss 6, Pp 61-66 (2021)
Objective: to study the frequency of hyperleptinemia in patients with systemic lupus erythematosus (SLE), its relationship with clinical and laboratory manifestations of the disease, drug therapy, and other metabolic disorders.Patients and methods. T
Externí odkaz:
https://doaj.org/article/5623051b13574be7a2b2a586e4b8ba91
Autor:
D. V. Kurkin, E. I. Morkovin, N. A. Osadchenko, D. A. Bakulin, E. E. Abrosimova, M. A. Dubrovina, N. S. Kovalev, Yu. V. Gorbunova, I. N. Tyurenkov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 8, Iss 6, Pp 426-435 (2021)
The aim of the study is an experimental confirmation of the use of a new combination of biologically active substances with tonic and antioxidant effects. This combination contains acetylcysteine in its composition to reduce the severity of psychoneu
Externí odkaz:
https://doaj.org/article/1a5992607c6545fe8625adaf05b9f403
Autor:
A. V. Martynova, T. V. Popkova, A. P. Aleksankin, G. I. Gridneva, E. V. Gerasimova, Yu. N. Gorbunova, A. S. Semashko, A. M. Lila
Publikováno v:
Современная ревматология, Vol 15, Iss 2, Pp 17-22 (2021)
Objective: to evaluate changes in T- and B-lymphocyte subpopulations at different stages of rheumatoid arthritis (RA).Patients and methods. The study included 53 patients with a definite RA diagnosis according to the 2010 ACR/EULAR criteria (mean age
Externí odkaz:
https://doaj.org/article/f16451cc9d3447f5aab95e789336a9f3
Autor:
Yu. N. Gorbunova, L. V. Kondratyeva, T. V. Popkova, N. V. Demin, A. V. Smirnov, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 1, Pp 70-74 (2021)
Aim of the study was to clarify the body composition in patients with early rheumatoid arthritis before starting therapy with synthetic basic anti-inflammatory drugs, genetically engineered biological drugs and glucocorticoids using dual-energy X-ray
Externí odkaz:
https://doaj.org/article/c9b1a3ff1ba5432996c071a3c5c69c7d
Autor:
I. G. Kirillova, D. S. Novikova, T. V. Popkova, H. V. Udachkina, E. I. Markelova, Yu. N. Gorbunova, Yu. O. Korsakova, S. N. Gluchova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 1, Pp 51-58 (2020)
Aim. To study the clinical manifestations and factors associated with the presence of chronic heart failure (CHF) in patients with early rheumatoid arthritis (RA) prior to anti-inflammatory therapy. Material and methods. The study included 74 patient
Externí odkaz:
https://doaj.org/article/cd015a1b2c0846859d6c58d8500c333c